80 related articles for article (PubMed ID: 8961808)
1. Single-chain Fv radioimmunotargeting.
Huston JS; George AJ; Adams GP; Stafford WF; Jamar F; Tai MS; McCartney JE; Oppermann H; Heelan BT; Peters AM; Houston LL; Bookman MA; Wolf EJ; Weiner LM
Q J Nucl Med; 1996 Sep; 40(3):320-33. PubMed ID: 8961808
[TBL] [Abstract][Full Text] [Related]
2. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv.
Adams GP; McCartney JE; Tai MS; Oppermann H; Huston JS; Stafford WF; Bookman MA; Fand I; Houston LL; Weiner LM
Cancer Res; 1993 Sep; 53(17):4026-34. PubMed ID: 7689421
[TBL] [Abstract][Full Text] [Related]
3. Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers.
Adams GP; Tai MS; McCartney JE; Marks JD; Stafford WF; Houston LL; Huston JS; Weiner LM
Clin Cancer Res; 2006 Mar; 12(5):1599-605. PubMed ID: 16533787
[TBL] [Abstract][Full Text] [Related]
4. Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.
George AJ; Jamar F; Tai MS; Heelan BT; Adams GP; McCartney JE; Houston LL; Weiner LM; Oppermann H; Peters AM
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8358-62. PubMed ID: 7667295
[TBL] [Abstract][Full Text] [Related]
5. Enhanced tumor specificity of 741F8-1 (sFv')2, an anti-c-erbB-2 single-chain Fv dimer, mediated by stable radioiodine conjugation.
Adams GP; McCartney JE; Wolf EJ; Eisenberg J; Huston JS; Bookman MA; Moldofsky P; Stafford WF; Houston LL; Weiner LM
J Nucl Med; 1995 Dec; 36(12):2276-81. PubMed ID: 8523119
[TBL] [Abstract][Full Text] [Related]
6. Targeting c-erbB-2 expressing tumors using single-chain Fv monomers and dimers.
Tai MS; McCartney JE; Adams GP; Jin D; Hudziak RM; Oppermann H; Laminet AA; Bookman MA; Wolf EJ; Liu S
Cancer Res; 1995 Dec; 55(23 Suppl):5983s-5989s. PubMed ID: 7493381
[TBL] [Abstract][Full Text] [Related]
7. Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administration.
Adams GP; McCartney JE; Wolf EJ; Eisenberg J; Tai MS; Huston JS; Stafford WF; Bookman MA; Houston LL; Weiner LM
Cancer Immunol Immunother; 1995 May; 40(5):299-306. PubMed ID: 7600561
[TBL] [Abstract][Full Text] [Related]
8. Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides.
McCartney JE; Tai MS; Hudziak RM; Adams GP; Weiner LM; Jin D; Stafford WF; Liu S; Bookman MA; Laminet AA
Protein Eng; 1995 Mar; 8(3):301-14. PubMed ID: 7479692
[TBL] [Abstract][Full Text] [Related]
9. Tumor targeting in a murine tumor xenograft model with the (sFv')2 divalent form of anti-c-erbB-2 single-chain Fv.
Huston JS; Adams GP; McCartney JE; Tai MS; Hudziak RM; Oppermann H; Stafford WF; Liu S; Fand I; Apell G
Cell Biophys; 1994; 24-25():267-78. PubMed ID: 7736532
[TBL] [Abstract][Full Text] [Related]
10. Medical applications of single-chain antibodies.
Huston JS; McCartney J; Tai MS; Mottola-Hartshorn C; Jin D; Warren F; Keck P; Oppermann H
Int Rev Immunol; 1993; 10(2-3):195-217. PubMed ID: 8360586
[TBL] [Abstract][Full Text] [Related]
11. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
Milenic DE; Yokota T; Filpula DR; Finkelman MA; Dodd SW; Wood JF; Whitlow M; Snoy P; Schlom J
Cancer Res; 1991 Dec; 51(23 Pt 1):6363-71. PubMed ID: 1933899
[TBL] [Abstract][Full Text] [Related]
12. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
Yokota T; Milenic DE; Whitlow M; Wood JF; Hubert SL; Schlom J
Cancer Res; 1993 Aug; 53(16):3776-83. PubMed ID: 8339291
[TBL] [Abstract][Full Text] [Related]
13. Improved tumor radioimmunodetection using a single-chain Fv and gamma-interferon: potential clinical applications for radioimmunoguided surgery and gamma scanning.
Nieroda CA; Milenic DE; Carrasquillo JA; Scholm J; Greiner JW
Cancer Res; 1995 Jul; 55(13):2858-65. PubMed ID: 7796413
[TBL] [Abstract][Full Text] [Related]
14. Rapid infarct imaging with a technetium-99m-labeled antimyosin recombinant single-chain Fv: evaluation in a canine model of acute myocardial infarction.
Nedelman MA; Shealy DJ; Boulin R; Brunt E; Seasholtz JI; Allen IE; McCartney JE; Warren FD; Oppermann H; Pang RH
J Nucl Med; 1993 Feb; 34(2):234-41. PubMed ID: 8429342
[TBL] [Abstract][Full Text] [Related]
15. Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules.
Schott ME; Milenic DE; Yokota T; Whitlow M; Wood JF; Fordyce WA; Cheng RC; Schlom J
Cancer Res; 1992 Nov; 52(22):6413-7. PubMed ID: 1423290
[TBL] [Abstract][Full Text] [Related]
16. Antigen recognition and targeted delivery by the single-chain Fv.
Huston JS; Tai MS; McCartney J; Keck P; Oppermann H
Cell Biophys; 1993; 22(1-3):189-224. PubMed ID: 7889539
[TBL] [Abstract][Full Text] [Related]
17. Crystallization of single-chain Fv proteins.
Essig NZ; Wood JF; Howard AJ; Raag R; Whitlow M
J Mol Biol; 1993 Dec; 234(3):897-901. PubMed ID: 8254684
[TBL] [Abstract][Full Text] [Related]
18. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody.
Pietersz GA; Patrick MR; Chester KA
J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738
[TBL] [Abstract][Full Text] [Related]
19. Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.
Hu S; Shively L; Raubitschek A; Sherman M; Williams LE; Wong JY; Shively JE; Wu AM
Cancer Res; 1996 Jul; 56(13):3055-61. PubMed ID: 8674062
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.
Pavlinkova G; Beresford GW; Booth BJ; Batra SK; Colcher D
J Nucl Med; 1999 Sep; 40(9):1536-46. PubMed ID: 10492377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
